Senesco Technologies, Inc. (SNT)’s SNS01-T to be Presented During Poster Session at 2012 Annual Meeting of the American Society of Clinical Oncology

5/30/2012 10:13:44 AM

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT), announced today that a poster describing the ongoing SNS01-T study in multiple myeloma will be presented at the 2012 Annual Meeting of the American Society of Clinical Oncology, June 1-5, 2012 in Chicago, Illinois. The abstract will be presented by Dr. John Lust, the principal investigator from the Mayo Clinic, Rochester, Minnesota.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• American Society of Clinical Oncology

• Senesco Technologies, Inc.

• Biotech/Pharma - Events